Conference Reports for NATAP

Conference on Retroviruses and Opportunistic Infections Seattle, Washington March 4-7, 2019 Back

Tweet

A Phase IIa Study of a Novel Maturation Inhibitor GSK2838232 in HIV patients       Reported by Jules Levin CROI 2019 March 4-7 Seattle WEBCAST: http://www.croiwebcasts.org/console/player/41311?mediaType=slideVideo&&crd_fl=0&ssmsrq=1552597508476&ctms=5000&csmsrq=5123